Group 2 Innate Lymphoid Cells in Respiratory Allergic Inflammation

• Published in: Frontiers in immunology Vol. 10; p. 930
• Main Authors: Helfrich, Sofia, Mindt, Barbara C., Fritz, Jörg H., Duerr, Claudia U.
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 07.06.2019
• Subjects: allergic inflammation; group 2 innate lymphoid cells (ILC2s); Immunology; mucosal immunity; respiratory tract; therapeutic strategies; allergic inflammation; group 2 innate lymphoid cells (ILC2s); respiratory tract; mucosal immunity; therapeutic strategies
• ISSN: 1664-3224; 1664-3224
• DOI: 10.3389/fimmu.2019.00930

Millions of people worldwide are suffering from allergic inflammatory airway disorders. These conditions are regarded as a consequence of multiple imbalanced immune events resulting in an inadequate response with the exact underlying mechanisms still being a subject of ongoing research. Several cell populations have been proposed to be involved but it is becoming increasingly evident that group 2 innate lymphoid cells (ILC2s) play a key role in the initiation and orchestration of respiratory allergic inflammation. ILC2s are important mediators of inflammation but also tissue remodeling by secreting large amounts of signature cytokines within a short time period. Thereby, ILC2s instruct innate but also adaptive immune responses. Here, we will discuss the recent literature on allergic inflammation of the respiratory tract with a focus on ILC2 biology. Furthermore, we will highlight different therapeutic strategies to treat pulmonary allergic inflammation and their potential influence on ILC2 function as well as discuss the perspective of using human ILC2s for diagnostic purposes.